Showing results (1191-1200 of 1,345) with videos related to

Sort By:
Pageof 135
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2020
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study)Stanley Cohen, Katie Tuckwell, Tamiko R Katsumoto, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
Head & Neck|March 3, 2022
Outcomes after definitive surgery for mandibular osteoradionecrosisKevin J Contrera, Steven B Chinn, Randal S Weber, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2005
Change in prevalence of IgE sensitization and mean total IgE with age and cohortDeborah Jarvis, Christina Luczynska, Susan Chinn, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
The European Respiratory Journal|March 2, 2006
Changes in active and passive smoking in the European Community Respiratory Health SurveyC Janson, N Künzli, R de Marco, et al.
Blood|October 28, 2010
First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 casesM Louise Markert, José G Marques, Bénédicte Neven, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2005
An increase in bronchial responsiveness is associated with continuing or restarting smokingSusan Chinn, Deborah Jarvis, Christina M Luczynska, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide librariesS D Yanofsky, D N Baldwin, J H Butler, et al.
Frontiers in Immunology|February 22, 2020
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2DEce Canan Sayitoglu, Anna-Maria Georgoudaki, Michael Chrobok, et al.
Pageof 135